Ever Source Wealth Advisors, LLC Crispr Therapeutics Ag Transaction History
Ever Source Wealth Advisors, LLC
- $1.65 Billion
- Q4 2024
A detailed history of Ever Source Wealth Advisors, LLC transactions in Crispr Therapeutics Ag stock. As of the latest transaction made, Ever Source Wealth Advisors, LLC holds 172 shares of CRSP stock, worth $7,033. This represents 0.0% of its overall portfolio holdings.
Number of Shares
172
Previous 1,480
88.38%
Holding current value
$7,033
Previous $69,000
91.3%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding CRSP
# of Institutions
488Shares Held
64.1MCall Options Held
1.64MPut Options Held
1.93M-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl8.97MShares$367 Million3.09% of portfolio
-
Capital International Investors Los Angeles, CA8.74MShares$358 Million0.07% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD3.81MShares$156 Million0.09% of portfolio
-
Black Rock Inc. New York, NY2.78MShares$114 Million0.0% of portfolio
-
Sumitomo Mitsui Trust Holdings, Inc.2.75MShares$112 Million0.07% of portfolio
About CRISPR Therapeutics AG
- Ticker CRSP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 78,009,296
- Market Cap $3.19B
- Description
- CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....